WVE
Wave Life Sciences Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$3.65
+2.00%Year over year
Reported trailing growth
- Revenue
- -35.1%
- EBITDA
- -72.0%
- EBIT
- -67.4%
- EPS
- -44.6%
- Free cash flow
- -1.7%
- Operating cash flow
- -1.4%
Forward estimates
Based on analyst estimates
- Revenue
- -45.4%
- EBITDA
- -29.8%
- EPS
- -25.9%
Three-year CAGR
- Revenue
- +127.1%
- EBITDA
- —
- EBIT
- -95.1%
- Net income
- —
- EPS
- -72.9%
- Free cash flow
- -23.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026